RAPT Therapeutics, Inc. (RAPT) Short-term Investments (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Short-term Investments for 5 consecutive years, with $60.0 million as the latest value for Q3 2024.
- Quarterly Short-term Investments fell 54.07% to $60.0 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $60.0 million through Sep 2024, down 54.07% year-over-year, with the annual reading at $111.4 million for FY2023, 46.99% down from the prior year.
- Short-term Investments hit $60.0 million in Q3 2024 for RAPT Therapeutics, down from $77.8 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $210.1 million in Q4 2022 to a low of $46.7 million in Q1 2020.
- Historically, Short-term Investments has averaged $123.8 million across 5 years, with a median of $130.6 million in 2023.
- Biggest five-year swings in Short-term Investments: skyrocketed 91.27% in 2021 and later tumbled 54.07% in 2024.
- Year by year, Short-term Investments stood at $86.6 million in 2020, then skyrocketed by 91.27% to $165.6 million in 2021, then grew by 26.86% to $210.1 million in 2022, then plummeted by 46.99% to $111.4 million in 2023, then plummeted by 46.13% to $60.0 million in 2024.
- Business Quant data shows Short-term Investments for RAPT at $60.0 million in Q3 2024, $77.8 million in Q2 2024, and $96.3 million in Q1 2024.